![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/04\/Screen-Shot-2021-04-16-at-3.25.08-PM.png\")
<\/p>\n
By\u00a0Edie Heipel<\/a> This article contains disturbing information about human dismemberment.<\/em><\/p>\n Last week, legal accountability group Judicial Watch dropped a bombshell: a nearly 600-page\u00a0report<\/a>\u00a0proving the U.S. government has been buying and trafficking \u201cfresh\u201d aborted baby body parts. These body parts, purchased by the U.S. Food and Drug Administration to \u201chumanize\u201d mice and test biologic drugs in scientific experiments, came from babies up to 24-weeks-old gestation, just weeks from being born.<\/p>\n While Americans may be used to hearing pro-lifers beat the warning drum on\u00a0abortion groups\u00a0harvesting baby bodies and selling them for research, (who hasn\u2019t heard of the\u00a0lawsuit<\/a>\u00a0against David Daleiden, who exposed Planned Parenthood\u00a0haggling<\/a>\u00a0over baby lungs and livers at dinner parties?) this time, the U.S. government was the one trafficking baby parts.<\/p>\n Recent emails uncovered by Judicial Watch between FDA employees and the California-based Advanced Bioscience Resources (ABR) prove the agency spent tens of thousands of dollars buying aborted babies for unethical scientific experiments between 2012 and 2018. In 2018, the Trump administration\u00a0terminated<\/a>\u00a0the contract, halting government fetal tissue research due to concerns the contracts were unlawful. Judicial Watch\u2019s new FOIA Request adds\u00a0575 pages of records<\/a>\u00a0<\/strong>to its existing 2019\u00a0lawsuit<\/a>\u00a0against the agency.<\/p>\n This is not the first time\u00a0ABR<\/a>\u00a0has been in the spotlight, as the company was under\u00a0congressional<\/a>\u00a0investigation for its long-standing involvement in fetal tissue trafficking. One of the oldest fetal tissue procurement firms, the company makes millions every year by harvesting organs like lungs, livers, eyeballs, and brains from aborted babies and re-selling them at a profit.<\/p>\n Emails between FDA officials and ABR employees reveal disturbing conversations as they collaborate to buy and sell aborted fetuses. Records\u00a0indicate<\/a>\u00a0ABR was paid $12,000 upfront per baby, some survivable out of the womb, between the gestational age of 16-24 weeks. Most purchases are for intact thymuses and livers shipped \u201cFresh; on wet ice.\u201d<\/p>\n With the callousness of picking a cut of meat from a butcher shop, an FDA doctor\u00a0requests<\/a>\u00a0tissue samples be procured from a baby boy, as they claim \u201cIt is strongly preferred to have a male fetus if at all possible \u2026 [but] undetermined sex or female is better than no tissue.\u201d<\/p>\n Even more appalling is an ABR employee\u00a0complaining<\/a>\u00a0about the difficulty of identifying the sex of aborted babies. \u201cWe only check external genitalia and if it\u2019s not there \u2026 we have no way of telling.\u201d The fact techs are unable to identify the sex of aborted babies is no surprise to those familiar with the barbaric nature of abortion procedures, which require clinic staff to piece together mangled remains of babies after their limbs and organs are torn apart.<\/p>\n As if these casual orders weren\u2019t horrific enough, more emails\u00a0confirm<\/a>\u00a0that the FDA bought organs of babies who were aborted well after 20 weeks gestation, after the time a baby usually can survive outside the womb. If nothing else, this confirms the reality of late-term abortions\u00a0<\/strong>in the United States, which pro-abortion cheerleaders have\u00a0denied\u00a0for decades.<\/p>\n When an ABR employee\u00a0reassured<\/a>\u00a0the FDA they were working with doctors who performed late-term abortions, he admitted some tissue was unusable from a procedure that injects a poison called\u00a0digoxin<\/a>\u00a0into the baby, destroying its cells and tissues. Once the chemical has done its work, an intact, dead baby is delivered. This method makes fetal tissue specimens\u00a0unusable<\/a>\u00a0in experiments; with digoxin off the table, the likelihood\u00a0partial-birth abortions<\/a>\u00a0were used is sickeningly high.<\/p>\n These conversations should shock even those who are pro-abortion,\u00a0most<\/a>\u00a0of whom believe in significant term restrictions. Babies at this level of development possess all characteristics necessary for surviving life outside the womb and premature children born as young as\u00a021 weeks<\/a>\u00a0go on to lead healthy, thriving lives.<\/p>\n These gruesome excerpts are just a sample of records substantiating the 2019\u00a0lawsuit<\/a>\u00a0Judicial Watch filed against HHS, which houses the FDA. In\u00a0March<\/a>\u00a0this year, a federal court ordered the agency to release records it withheld about purchasing organs of aborted babies,\u00a0saying<\/a>\u00a0it found \u201creason to question\u201d the transactions violated federal law.<\/p>\n
\nAPRIL\u00a015, 2021<\/p>\nCaught Red-Handed<\/strong><\/h2>\n
An Atrocity Against Human Dignity<\/strong><\/h2>\n